Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Robert Tarran
Univ of North Carolina Chapel Hill, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Spyryx Biosciences, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The SFIs of the investigator are related to the funded research since the technology being used in the project has been licensed to the company with which the investigator has multiple relationships. Please be aware that UNC Chapel Hill includes royalties from the University in their assessment. This figure is the amount anticipated to occur in the next 12 months. As of 08/16/2016. no dollars have been received by Dr. Tarran.
The Institution has determined that since the technology could be further validated as a result of the research, these financial interests could conflict with project.
SPLUNC1-Derived Peptides as ENaC Antagonists
CF mucus is dehydrated due to a genetically induced imbalance in salt and water transport in the lungs, leaving the airways prone to mucus plugging and recurrent infections. In this application, we propose to understand how CF airways can regulate salt and water transport to maintain mucus clearance. We also propose to develop novel peptides that can inhibit excessive salt absorption in CF airways to improve CF mucus hydration.
Filed on August 29, 2016.
Tell us what you know about Robert Tarran's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Robert Tarran filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Robert Tarran | Univ of North Carolina Chapel Hill | Conflict of Interest | Spyryx Biosciences, Inc. | $60,000 - $79,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.